Abstract
The widespread use of amorphous solid dispersions (ASDs) dictates that analytical methods are required to accurately quantify crystallinity and characterize crystals formed in order to help design a stable ASD. Current crystallinity quantitation methods are limited to ASDs of moderate drug loadings, single polymorphs, and fast crystallization kinetics. The ability of multiple differential scanning calorimetry (DSC), powder X-ray diffraction (PXRD), and solid-state nuclear magnetic resonance (SSNMR) techniques were compared for quantifying crystallinity in ASDs in varying conditions. Determining crystallinity by DSC is limited by its ability to measure Tg or heat of fusion. PXRD was relatively robust in determining crystalline and amorphous ratios for drug-polymer systems in the absence of other excipients. SSNMR provides both quantitative information and reveal how crystal quality changes with crystallization conditions and helps to explain the failure of DSC methods. The results of five different methods using three techniques were directly applied to measure drug-in-polymer solubility with four agreeing well with the literature. PXRD and SSNMR are therefore proposed as alternative methods to quantify crystallinity and predict drug-in-polymer solubility when DSC methods do not work. In-situ and ex-situ annealing was also compared, and equivalent crystallinity data was acquired.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
